Clinical Trials Logo

Suicide Prevention clinical trials

View clinical trials related to Suicide Prevention.

Filter by:

NCT ID: NCT05345184 Recruiting - Suicide Clinical Trials

Cognitive Behavioral Suicide Prevention for Psychosis: Aim 2

Start date: September 1, 2022
Phase: N/A
Study type: Interventional

Investigators will evaluate the feasibility and preliminary effectiveness of modified Cognitive Behavioral Suicide Prevention for psychosis (CBSPp) in comparison to services-as-usual (SAU) in a randomized controlled trial. Investigators will recruit adult clients receiving services at a community mental health (CMH) setting who have a schizophrenia spectrum disorder and recent suicidal thoughts or behaviors within 3 months of screening (n=60). Client participants will be screened, enrolled and randomized to the CBSPp or SAU group. A 4-wave design will include quantitative assessments at baseline (T1), 1-month after baseline (T2), 3-months after baseline (T3), and 5-months after baseline (T4) with in-depth qualitative interviews at T3 for a random sample of adults in the CBSPp group (n=10). Providers (n=12) will be trained to deliver CBSPp and be assessed from T1-T3 to evaluate the implementation process, including in-depth qualitative interviews at T3.

NCT ID: NCT05304065 Recruiting - Clinical trials for Suicide and Self-harm

Youth Partners in Care for Suicide Prevention

YPIC-SP
Start date: October 17, 2022
Phase: Phase 2
Study type: Interventional

This randomized comparative effectiveness trial will compare two evidence-based approaches to emergency care for youth ages 15-24 who present to the Emergency Department (ED) with suicidal ideation or behavior. OUtcomes will be monitored at baseline and at 3, 6 & 12 month follow-up assessments.

NCT ID: NCT05275101 Recruiting - Suicide Clinical Trials

Neural Mechanisms and Predictors of an Ultra-Brief Suicide Prevention Strategy

Start date: July 28, 2021
Phase: N/A
Study type: Interventional

The current study is a clinical trial, meaning a research study in which human subjects are prospectively assigned to one or more interventions to evaluate the effects of those interventions on health-related behavioral outcomes. Specifically, male and female adults with current suicidal intent will be randomly assigned to receive either a 1-hour session of crisis response planning (CRP) or a 1-hour session of standard crisis risk management (Treatment as Usual). The effects of both conditions on changes in emotion regulation, behavioral inhibition, stress reactivity, and suicide risk will be evaluated post-intervention and at six-month follow-up. Additional assessments of changes in mood and suicidality will be collected daily during the first 10-days following intervention, and then monthly for a duration of six months. A cohort of healthy controls is included in the study but are not randomized to either treatment condition. The investigators hypothesize the following: 1) A single session of CRP will acutely change suicide risk and 2) Individuals who receive CRP will show sustained improvements in measures of suicidality when compared to individuals who received the Treatment as Usual intervention.

NCT ID: NCT05225103 Recruiting - Suicide Prevention Clinical Trials

Brief Suicide Intervention for Youth in Juvenile Detention Settings

Start date: April 7, 2023
Phase: N/A
Study type: Interventional

This is an intervention development study and therefore is not designed or powered to test hypotheses. Following initial development and refinement of intervention and protocol, an open trial will be conducted at one juvenile detention facility (n=20). Following further refinement, six juvenile detention sites will be randomized to first or second wave of intervention implementation. All youth at an implementation site in suicidal crises will receive the intervention. Data will only be collected from youth with prior assent/consent. Youth will be assessed at the time of the suicidal/self-harm crisis, and at 2 and 4 weeks after initial intervention, and at a two-month follow-up assessment. We will preliminarily examine feasibility of the intervention and associated patterns of suicidal thoughts and behavior and non-suicidal self-injury, linkage to care following release, and presumed mechanisms of change such as hopelessness, self-efficacy to remain safe, urgency to act on suicidal thoughts, and acceptance.

NCT ID: NCT05178121 Completed - Suicide Clinical Trials

eLearning for Suicide Prevention

Start date: November 1, 2021
Phase: N/A
Study type: Interventional

Project WISE (Workplace Integrated Support & Education) includes developmental and pilot research to create an e-learning training in suicide safety planning enhanced with novel skill-building technologies that can be integrated into the routine workflow of nurses serving patients hospitalized for medical, surgical, or traumatic injury reasons. This study pilots an initial version of this eLearning training and collects data on the acceptability of the training and its components as well as engagement of nurses in the training. The evaluation will inform iterations of the training.

NCT ID: NCT05172609 Enrolling by invitation - Clinical trials for Implementation Science

An Exposure-Based Implementation Strategy to Decrease Clinician Anxiety Around Suicide Prevention

Start date: March 29, 2023
Phase: N/A
Study type: Interventional

Study objectives are to design and pilot test a novel, exposure-based implementation strategy (EBIS) directly targeting clinician anxiety and low self-efficacy for use of evidence-based suicide screening, assessment, and intervention (SSAI) strategies with patients at risk for suicide in community settings. Early phases of this study will develop the EBIS in partnership with community clinicians (n = 15). The last phase of this study is a pilot clinical trial in which 40 community mental health clinicians will be randomized to receive either implementation as usual (IAU) or IAU+EBIS.

NCT ID: NCT05128227 Completed - Suicide Clinical Trials

PHARM-S.A.V.E.S: Suicide Prevention Training

Start date: April 15, 2022
Phase: N/A
Study type: Interventional

This is a pilot Randomized Controlled Trial (RCT) in which 150 pharmacy staff members will be randomized to an experimental or control group and data on suicide prevention communication and secondary outcomes will be collected over the course of the RCT.

NCT ID: NCT05127330 Completed - Suicide Clinical Trials

Pilot RCT of a Video-based Intervention for Suicide Prevention

Start date: January 1, 2022
Phase: N/A
Study type: Interventional

The investigators will develop a brief video-based intervention for suicide prevention, called LifePlans. LifePlans will be tested in a pilot randomized controlled trial (n = 40) to examine its feasibility and acceptability. Investigators will recruit patients admitted to a psychiatric hospital for suicidal thoughts and behaviors who will receive the intervention for 4 weeks post-discharge. Patients will be assessed at hospital baseline, 1 month post-discharge, and 6 months post-discharge.

NCT ID: NCT05087966 Completed - Suicide Clinical Trials

Suicide Prevention for Sexual and Gender Minority Youth (Open Trial)

Start date: November 8, 2021
Phase: N/A
Study type: Interventional

The overarching goal of this study is to develop a suicide prevention program for sexual-and-gender-minority youth and emerging adults. After development of the intervention program, an open phase trial will be conducted to test its feasibility, acceptability, and preliminary impact on three intervention targets.

NCT ID: NCT05067686 Recruiting - Suicide Clinical Trials

Health Professionals Perspective on Suicide

Start date: October 1, 2021
Phase:
Study type: Observational

The aim is to investigate how health professionals view/respond towards suicidal patients, what was their attitude, experiences and difficulties/challenges they faced while dealing with suicidal patients (whether successful or unsuccessful), and what measures/methods are optimal or could be used to prevent suicide from the perspective of mental and non mental health professionals through concurrent mixed methods study approach.